187 (Carbidopa and levodopa (orally disintegrating) 25 mg / 100 mg)

Pill imprint 187 has been identified as Carbidopa and levodopa (orally disintegrating) 25 mg / 100 mg.

Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substance Act (CSA).

Carbidopa and levodopa (orally disintegrating)

Imprint:

187

Strength:

25 mg / 100 mg

Color:

Yellow

Shape:

Round

Availability:

Prescription only

Drug Class:

Dopaminergic antiparkinsonism agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Sun Pharmaceuticals

National Drug Code (NDC):

62756-0187

Inactive Ingredients:

povidone
mannitol
calcium silicate
crospovidone
magnesium silicate
magnesium stearate
aspartame
silicon dioxide colloidal
microcrystalline cellulose
D&C Yellow No. 10
FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
47335-0187	Sun Pharmaceutical Industries Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.